Search - tctmd.com

Displaying 281 - 300 of 647

Sort: Relevancy | Date

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

May 06, 2020

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

April 01, 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

Statins May Have Protective Effect on Chemotherapy-Induced Cardiotoxicity

News Conference News ACC 2020

Statins May Have Protective Effect on Chemotherapy-Induced Cardiotoxicity

Yael L. Maxwell

March 19, 2020

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

News Daily News

Meta-analysis Reassures on Benefits of TAVR in Cancer Patients

March 16, 2020

One Egg a Day? No Link to Risk of CVD, Mega-Meta-analysis Says

News Daily News

One Egg a Day? No Link to Risk of CVD, Mega-Meta-analysis Says

Michael O'Riordan

March 06, 2020

Habitual Use of Fish Oil Prevents CVD, Real-world Data Suggest

News Daily News

Habitual Use of Fish Oil Prevents CVD, Real-world Data Suggest

March 05, 2020

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

News Daily News

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

February 14, 2020

Trials of New Cancer Drugs Failing to Address Potential CV Risks

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

February 10, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

January 31, 2020

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

News Daily News

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

January 29, 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

News Conference News ISET 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

January 23, 2020

Overuse of CT Scans for Suspected Pulmonary Embolism Persists

News Daily News

Overuse of CT Scans for Suspected Pulmonary Embolism Persists

January 23, 2020

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

January 14, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

January 14, 2020

The Cancer Patient Needing PCI Poses Conundrums for Care

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

January 14, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.